n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Bacterial Disease in 6 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On Day 7 after trauma, mice were sacrificed, serum was collected, and splenic macrophages were evaluated for PGE(2), LTB(4), IL-6, TNF-alpha, and NO production." | 1.31 | NS-398 treatment after trauma modifies NF-kappaB activation and improves survival. ( Concannon, EM; Daly, JM; Mack Strong, VE; Mackrell, PJ; Mestre, JR; Schaefer, PA; Smyth, GP; Stapleton, PP, 2001) |
| "This hyperalgesia was observed only in the period before the development of fever which started 120-135 min after the LPS injection." | 1.31 | Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats. ( Abe, M; Hori, T; Oka, T; Takahashi, S, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qian, X | 1 |
| Zhang, J | 1 |
| Liu, J | 1 |
| Shoup, M | 1 |
| He, LK | 1 |
| Liu, H | 1 |
| Shankar, R | 1 |
| Gamelli, R | 1 |
| Mack Strong, VE | 1 |
| Mackrell, PJ | 1 |
| Concannon, EM | 1 |
| Mestre, JR | 1 |
| Smyth, GP | 1 |
| Schaefer, PA | 1 |
| Stapleton, PP | 1 |
| Daly, JM | 1 |
| Reddy, RC | 1 |
| Chen, GH | 1 |
| Tateda, K | 1 |
| Tsai, WC | 1 |
| Phare, SM | 1 |
| Mancuso, P | 1 |
| Peters-Golden, M | 1 |
| Standiford, TJ | 1 |
| Abe, M | 1 |
| Oka, T | 1 |
| Hori, T | 1 |
| Takahashi, S | 1 |
| Schwacha, MG | 1 |
| Chung, CS | 1 |
| Ayala, A | 1 |
| Bland, KI | 1 |
| Chaudry, IH | 1 |
6 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Bacterial Disease
| Article | Year |
|---|---|
Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Infections; Cell Line; Chemokine CCL5; C | 2011 |
Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Infections; Burns; Cyclooxygenase Inhibi | 1998 |
NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
Topics: Animals; Bacterial Infections; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibit | 2001 |
Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis.
Topics: Animals; Bacterial Infections; Body Temperature Regulation; Cecum; Cyclooxygenase 2; Cyclooxygenase | 2001 |
Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats.
Topics: Animals; Bacterial Infections; Body Temperature; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase | 2001 |
Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury.
Topics: Animals; Bacterial Infections; Burns; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2002 |